5 things to watch on the ASX 200 on Friday

ResMed Inc. (ASX:RMD) and Woodside Petroleum Limited (ASX:WPL) shares will be on watch on the ASX 200 on Friday. Here's why…

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Thursday the S&P/ASX 200 Index (ASX: XJO) was out of form and dropped notably lower. The benchmark index fell 0.9% to 5,936.5 points.

Will the market be able to bounce back from this on Friday? Here are five things to watch:

ASX 200 expected to edge lower.

The ASX 200 looks set to end the week on a subdued note on Friday. According to the latest SPI futures, the benchmark index is expected to open the day 4 points or 0.1% lower. This follows a mixed night of trade on Wall Street which has seen the Dow Jones fall 0.15%, but the S&P 500 rise 0.05% and the Nasdaq index climb 0.35% higher. This was the latter's fifth straight gain.

Oil prices rebound.

It could be a strong finish to the week for energy producers such as Beach Energy Ltd (ASX: BPT) and Woodside Petroleum Limited (ASX: WPL) after oil prices rebounded. According to Bloomberg, the WTI crude oil price is up 2.5% to US$38.90 a barrel and the Brent crude oil price has pushed 2% higher to US$41.53 a barrel. Oil prices rebounded on OPEC+ output optimism.

Gold price edges lower.

Gold miners including Newcrest Mining Limited (ASX: NCM) and Saracen Mineral Holdings Limited (ASX: SAR) could end the week on poor note after the gold price weakened. According to CNBC, the spot gold price is down 0.3% to US$1,730.50 an ounce. The price of the precious metal softened after U.S. jobless claims fell.

ResMed rated as a buy.

The ResMed Inc. (ASX: RMD) share price could go higher from here according to analysts at Goldman Sachs. This morning the broker has reaffirmed its buy rating and $27.00 price target on the medical device company's shares. Goldman hosted a call with ResMed's management yesterday and notes that demand for Obstructive Sleep Apnoea (OSA) products has remained robust during the pandemic.

Woodside given buy rating.

In addition to ResMed, Goldman Sachs is positive on Woodside Petroleum. It has reaffirmed its buy rating and $33.85 price target on the energy producer's shares. This price target implies potential upside of 55.6% for its shares over the next 12 months.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has recommended ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

three men stand on a winner's podium with medals around their necks with their hands raised in triumph.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a festive start to the short trading week this Monday.

Read more »

A man looking at his laptop and thinking.
Broker Notes

Buy, hold, sell: Develop Global, Metcash, and Treasury Wine shares

Let's see what analysts are saying about these shares.

Read more »

Two university students in the library, one in a wheelchair, log in for the first time with the help of a lecturer.
Broker Notes

Leading brokers name 3 ASX shares to buy today

Here's why brokers believe that now could be the time to snap up these shares.

Read more »

A young bank customer wearing a yellow jumper smiles as she checks her bank balance on her phone.
Share Market News

Infratil gets investment grade credit rating in funding milestone

Infratil has received an inaugural investment grade credit rating from S&P Global Ratings, supporting future growth and funding options.

Read more »

Australian dollar notes in the pocket of a man's jeans, symbolising dividends.
Broker Notes

Up 109% in a year, 3 reasons to buy this ASX All Ords share today

A leading broker expects this surging ASX All Ords share to outperform again in 2026.

Read more »

Overjoyed man celebrating success with yes gesture after getting some good news on mobile.
Share Gainers

Why DroneShield, Meteoric Resources, NextDC, and Nick Scali shares are charging higher today

These shares are starting the week with a bang. But why?

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Opinions

$5,000 to spare? I'd buy these 5 ASX 200 shares before the end of 2025

These shares look like a good buy to me right now.

Read more »

Bored man sitting at his desk with his laptop.
Share Fallers

Why Domino's, HMC Capital, Regis Healthcare, and WiseTech shares are falling today

These shares are starting the week in the red. But why?

Read more »